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We investigated the cytotoxic activity of 2-substituted
naphtho[2,3-b]furan-4,9-diones. We have previously
synthesized 33 types of 2-substituted and related com-
pounds, and the cytotoxic activity of these compounds
was then examined by a KB cell culture assay. 2-(3-
Furanoyl)benzoic acids and 1,4-naphthoquinones had
no activity. 2-Acetyl-4,9-dimethoxynaphtho[2,3-b]furan
4 showed low activity. However, parent naphtho[2,3-
b]furan-4,9-dione 2 and most 2-substituted derivatives
exhibited cytotoxic activity. The parent structure was
therefore for cytotoxicity. 2-Formylnaphtho[2,3-b]-
furan-4,9-dione 11 had particularly potent activity
(ED50 ¼ 0:09g/ml).
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Several naphtho[2,3-b]furan-4,9-diones with interest-
ing biological activities have been isolated from plants.1)
For example, 2-acetylnaphtho[2,3-b]furan-4,9-dione 1
isolated from Tabebuia cassinoides (Lam.) DC (Bigno-
niaceae) exhibited cytotoxic activity.2) Hayashi et al.3)
have reported that the cytotoxic activity of 2-methyl-
naphtho[2,3-b]furan-4,9-dione was three times that of 1.
The activity of 2-substituted naphtho[2,3-b]furan-4,9-
diones varies with the type of substituent on parent
naphtho[2,3-b]furan-4,9-dione 2. Although organic
chemists are interested in synthesizing these com-
pounds, a convenient method to directly introduce
substituents on to the 2-position of 2 has not previously
been elucidated.
We recently began to focus on the synthesis of 2-
substituted compounds, and have reported the prepara-
tion of parent compound 2,4) natural product 1,5,6) 2-
trimethylsilylnaphtho[2,3-b]furan-4,9-dione 9,6) 2-(2-
methyl-1,3-dioxolan-2-yl)naphtho[2,3-b]furan-4,9-dione
10,6) and 2-formylnaphtho[2,3-b]furan-4,9-dione 11.6)
Halodesilylation and nitrodesilylation of 9 have been
reported in connection with studies to prepare the 2-
substituted compounds. 2-Chloronaphtho[2,3-b]furan-
4,9-dione 12, 2-bromonaphtho[2,3-b]furan-4,9-dione
13, 2-iodonaphtho[2,3-b]furan-4,9-dione 14, and 2-
nitronaphtho[2,3-b]furan-4,9-dione 15 have subsequent-
ly been obtained in good yields.6) Furthermore, 12 has
been treated with carbon,7,8) oxygen,7) sulfur,7,8) and
nitrogen8,9) nucleophiles to give desired compounds 16–
42. We are interested in the cytotoxic activity of the
obtained 2-substituted derivatives. We examine in the
present study the activity of the derivatives by using a
KB cell culture assay according to the NIH protocol.10)
We were also interested in the activity of related
compounds without the parent structure, so we tested
the activity of the following compounds in the same
manner: 4,9-dimethoxynaphtho[2,3-b]furan 36) and 2-
acetyl-4,9-dimethoxynaphtho[2,3-b]furan 4,6) intermedi-
ates with a reduced parent structure that were formed
during the synthesis of 2-substituted naphtho[2,3-b]-
furan-4,9-dione; 2-(3-furanoyl)benzoic acid 54) and
2-(2-acetyl-4-furanoyl)benzoic acid 6,6) intermediates
without a tricyclic structure that were formed during the
synthesis of parent 1 and the short synthesis of the parent
structure; and 1,4-naphthoquinones 7 and 8,7) decom-
position products lacking a furan ring that were isolated
during the reaction of compound 12 with an oxygen
nucleophilic agent. Tables 1, 2 and 3 show the structures
of all the compounds tested in the present study and their
cytotoxicity (ED50).
There is only one report regarding the biological
activity of parent 2. It has been reported that 2 exhibited
inhibitory activity against the Epstein-Barr virus early
antigen (EBA-VA) activation introduced by 12-O-
tetradecanoylphorbol-13-acetate (TPA).11) The cytotoxic
activity of 2 was initially investigated, and it was found
to exhibit cytotoxic activity in the KB cell culture assay
(ED50 ¼ 0:6 mg/ml). We then investigated the activity
of related compounds 3–8 without the parent structure,
and the results showed that, while compounds 3, 5, 6, 7
and 8 were not cytotoxic, compound 4 was mildly
cytotoxic (ED50 ¼ 6:4 mg/ml) (Table 1).
We subsequently studied the eﬀects of substituents at
the 2-position for cytotoxic activity. First, the activity of
those compounds having a carbon bond at the 2-position
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was studied. Compound 10, which has the acetyl group
of 1 protected by a ketal, showed strong activity
(ED50 ¼ 0:4 mg/ml), while 2-formyl compound 11 ex-
hibited stronger activity (ED50 ¼ 0:09 mg/ml). Com-
pounds 16 and 17, which possess bulky substituent
groups, showed moderate activity.
2-Phenoxy compound 18 and 2-phenylthio compound
19 showed similar activities; however, the activity of 2-
methylthio compound 20 was three times stronger than
that of 19. The bulky substituent group at the 2-position
may thus have decreased the cytotoxic activity. Halogen
derivatives 12–14 were also examined, with 2-chloro
compound 12, which has the smallest group among the
derivatives, showing the strongest activity, while 2-
trimethylsilyl compound 9 had moderate activity
(Table 2).
The activity of those compounds having a nitrogen
bond at the 2-position was also studied. 2-Nitro com-
pound 15 had strong activity (ED50 ¼ 0:2 mg/ml). When
the nitro group was reduced to a hydroxyamino group, it
Table 1. ED50 Values (mg/ml) of Naphtho[2,3-b]furan-4,9-dione, 4,9-Dimethoxynaphtho[2,3-b]furans, 2-(3-Furanoyl)benzoic Acids and 1,4-
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acted as an aromatic amidation agent for nucleic acid.
2-Azido compound 21 also showed cytotoxic activity
(ED50 ¼ 1:0 mg/ml). Compounds 22–26, which have
aliphatic secondary amino residues, were also tested. 2-
Propylamino compound 22, having the smallest sub-
stituent group among the derivatives, showed the
strongest activity. Branched isomer 23 had lower
activity than 22. Among the butylamino derivatives,
branched derivatives 25 and 26 had lower activities than
straight-chain derivative 24. Compounds 27–29, having
aliphatic tertiary amino residues, were then tested. 2-
Dimethylamino compound 27 was more active than 2-
diethylamino compound 28, while 2-diisopropylamino
compound 29 had no activity. The activities of com-
pounds 30–41, which have cyclic amino residues were
also investigated. The activity was highest in 5-member
ring 30, followed by 6-member ring 32, 7-member ring
40 and 8-member ring 41. It is interesting that 2-(3-
pyrrolin-1-yl) compound 31 showed no cytotoxic activ-
ity, despite the presence of a 5-member ring. 2-(2-
Methylpiperidino) compound 33 showed similar activity
to 32. 2-(4-Methylpiperidino) compound 35 had lower
activity than 32, while 2-(3-methylpiperidino) com-
pound 34 had no activity. N-Substituted piperazinyl
compounds 36–38 had cytotoxic activity, with 38
showing the strongest activity among the derivatives
(ED50 ¼ 0:6 mg/ml). 2-Morpholino compound 39
showed high activity (ED50 ¼ 0:7 mg/ml). The activities
of 38 and 39 were stronger than those of the other cyclic
amino compounds. 2-(1-Imidazolyl) compound 42 also
showed strong activity (ED50 ¼ 0:2 mg/ml) (Table 2,
Table 3).
Compounds 3, 5, 6, 7 and 8 had no cytotoxic activity,
while 4 showed only low activity in our examination.
Parent 2 and almost all of its derivatives possessed
cytotoxic activity, and parent structure 2 thus appears to
be necessary for cytotoxicity. We found that the activity
of the 2-substituted compounds varied with the type of
substituent group, although both electron-withdrawing
groups and electron-donating groups at the 2-position
exhibited cytotoxic activity. We demonstrated that
neither an inductive eﬀect nor resonance eﬀect at the
2-position had any eﬀect on cytotoxicity. Some com-
pounds were more active than parent 2. It was found that
some substituent groups at the 2-position increased the
activity. However, bulky substituent groups at the 2-
position decreased the activity. Chang and Chen12) have
reported that the carcinostatic mechanism of morinda-
parvin-A, which has an anthraquinone structure, was
intercalation to DNA. Intercalation was thus assumed to
be the cytotoxic mechanism of naphtho[2,3-b]furan-4,9-
diones. However, among the compounds with bulky
substituent groups, the activities of compounds 10, 38
and 39, which possess an oxygen atom, were marked,
while those of compounds 16 and 17 were moderate.
Hydrogen bonding to DNA thus appears to be involved
in cytotoxicity. Kim et al.13) have reported that the
formyl and nitro groups on the benzimidazoles acted as
hydrogen bond acceptors, and as a result, hydrogen
bonding of formyl-derivative 11 and nitro-derivative 15
to DNA may have enhanced the cytotoxicity.
On the other hand, Lown et al.14) have reported that
the activity of carcinostatic agents having an anthraqui-
none structure was inhibited by superoxide dismutase
(SOD). They suggested that the hydroxyl radical was the
active intermediate of these agents. When 3, which has a
quinone moiety, was reduced, it exhibited no cytotoxic
activity, and thus the free radicals were concluded to be
Table 3. ED50 Values (mg/ml) of 2-Substituted Naphtho[2,3-b]furan-4,9-diones (2)
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involved in the cytotoxic mechanism of naphtho[2,3-
b]furan-4,9-diones. Furthermore, Bhashyam et al.15)
have reported that the presence of basic nitrogen
enhanced the activity of drugs that intercalate DNA.
This supports the results of the present study; the
activity of compound 42, which possesses an imidazole
group, was high, while almost all the compounds
synthesized by nitrogen nucleophilic substitution were
cytotoxic. Coste et al.16) have reported that such
aldehydes as formaldehyde and 2-furaldehyde formed
DNA-protein cross-links, and as a result, the same action
mechanism may be involved with compound 11,
possessing a formyl group, which exhibited the strongest
activity in this study.
In conclusion, intercalation to DNA and free radicals
are thought to be involved in the cytotoxicity of
naphtho[2,3-b]furan-4,9-diones. The derivatives have
such potent activity because these mechanisms act
together. To obtain a more active compound, further
studies on the preparation of compounds having suitable
substituent groups (size and hydrogen bonds) are in
progress, and the results will be reported in due course.
Experimental
Cytotoxic screening of the 42 compounds was con-
ducted according to NIH protocol. KB cells were
incubated with 2 104 tumor cells grown in MEM +
10% fetal calf serum at 37 C at a 10 angle for 72 h.
Each drug was dissolved in dimethyl sulfoxide (0.01
ml), which did not inhibit normal growth, and was tested
at 0.04 to 10 mg/ml (N ¼ 4). Protein determinations
were made for all the test and control tubes, standards
and medium blanks according to the method of Oyama
and Eagle.17) ED50 is the calculated eﬀective dose that
inhibited growth to 50% that of the control.
References
1) Tisler, M., ‘‘Heterocyclic Quinones in Advances in
Heterocyclic Chemistry’’ Vol. 45, ed. Katritzky, A. R.,
Academic Press, London, pp. 56–63 (1989).
2) Rao, M. M., and Kingston, D. G. I., Plant anticancer
agents. XII. Isolation and structure elucidation of new
cytotoxic quinines from Tabebuia cassinoides. J. Nat.
Prod., 45, 600–604 (1982).
3) Hayashi, T., Smith, F. T., and Lee, K.-H., Antitumor
agents. 89. Psychorubin, a new cytotoxic naphthoqui-
none from Psychotria rubra and its structure—activity
relationships. J. Med. Chem., 30, 2005–2008 (1987).
4) Koyanagi, J., Yamamoto, K., Nakayama, K., and
Tanaka, A., A short-step synthesis of naphtho[2,3-
b]furan-4,9-dione. J. Heterocycl. Chem., 31, 1303–
1304 (1994).
5) Koyanagi, J., Yamamoto, K., Nakayama, K., and
Tanaka, A., A facile synthesis of 2-acetylnaphtho[2,3-
b]furan-4,9-dione. J. Heterocycl. Chem., 32, 1289–1291
(1995).
6) Koyanagi, J., Yamamoto, K., Nakayama, K., and
Tanaka, A., A new synthetic route to 2-substituted
naphtho[2,3-b]furan-4,9-dione. J. Heterocycl. Chem., 34,
407–412 (1997).
7) Koyanagi, J., Yamamoto, K., Nakayama, K., and
Tanaka, A., Nucleophilic substitutions of 2-halo-
naphtho[2,3-b]furan-4,9-diones and 2-nitronaphtho[2,3-
b]furan-4,9-dione. Chem. Pharm. Bull., 45, 1579–1581
(1997).
8) Koyanagi, J., Yamamoto, K., Sugaya, A., Tsuda, T.,
Ohguchi, H., Nakayama, K., Tanaka, A., and Ogawa, M.,
Synthesis of naphtho[2,3-b]furan-4,9-dione derivatives.
4. Abstracts of papers, the 118th Annual Meeting of the
Pharmaceutical Society of Japan, Kyoto, March 1998,
No. 2, p. 87.
9) Koyanagi, J., Ogawa, M., Yamamoto, K., Nakayama, K.,
and Tanaka, A., Nucleophilic substitutions of 2-chloro-
naphtho[2,3-b]furan-4,9-dione with amines. J. Hetero-
cycl. Chem., 35, 301–305 (1998).
10) Geran, R. I., Greenberg, N. H., Macdonald, M. M.,
Schumacher, A. M., and Abbot, B. J., Protocols for
screening chemical agents and natural products against
animal tumors and other biological systems. Cancer
Chemother. Rep., 3, 17–27 (1972).
11) Konoshima, T., Kozuka, M., Koyama, J., Okatani, T.,
Tagahara, K., and Tokuda, H., Studies on inhibitors of
skin tumor promotion, IV. Inhibitory eﬀects of quinones
on Epstein-Barr virus activation. J. Nat. Prod., 52, 987–
995 (1989).
12) Chang, P., and Chen, C.-F., Antineoplastic anthraqui-
nones. II. Design and synthesis of 1,2-heteroannelated
anthraquinones. J. Heterocycl. Chem., 33, 367–371
(1996).
13) Kim, J. S., Sun, Q., Gatto, B., Yu, C., Liu, A., Liu, L. F.,
and LaVoie, E. J., Structure-activity relationships of
benzimidazoles and related heterocycles as topoisomer-
ase I poisons. Bioorg. Med. Chem., 4, 621–630 (1996).
14) Lown, J. W., Sim, S.-K., Majumdar, K. C., and Chang,
R.-Y., Strand scission of DNA by bound adriamycin and
daunorubicin in the presence of reducing agents.
Biochem. Biophys. Res. Commun., 76, 705–710 (1977).
15) Iyengar, B. S., Dorr, R. T., Alberts, D. S., Solyom, A.
M., Krutzsch, M., and Remers, W. A., 1,4-Disubstituted
anthracene antitumor agents. J. Med. Chem., 40, 3734–
3738 (1997).
16) Costa, M., Zhitkovichi, A., Harris, M., Paustenbach, D.,
and Gargas, M., DNA-protein cross-links reduced by
various chemicals in cultured human lymphoma cells.
J. Toxicol. Environ. Health, 50, 433–449 (1997).
17) Oyama, V. I., and Eagle, H., Measurement of cell growth
in tissue culture with a phenol reagent (Foline-Ciocal-
teau). Proc. Soc. Exp. Biol. Med., 91, 305–307 (1956).
1012 M. OGAWA et al.
